Best practices in the use of human immunoglobulin preparations for intravenous administration in the treatment of rare neurological diseases
Aim. To describe best practices in using human normal immunoglobulin in patients with immune-mediated neurological disorders according to the data of one clinical center.Materials and methods. From 2016 to 2021, 20 patients with various autoimmune disorders of the peripheral and central nervous syst...
Saved in:
| Main Authors: | N. M. Tereshchenko, Ya. B. Kushnir, M. P. Abramova, A. A. Gotovchikov, V. S. Krasnov, A. Y. Sokolov, N. A. Totolyan, A. V. Amelin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2023-04-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/5142 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does the Use of Intravenous Immunoglobulin Improve Clinical Outcomes in Adults With Autoimmune Encephalitis? A Systematic Review
by: Anahat Kalra, et al.
Published: (2025-05-01) -
Post-COVID-19 Guillain-Barre Syndrome: A Distinct Neurological Entity
by: Ritika Sud, et al.
Published: (2021-01-01) -
Specific features of chronic inflammatory demyelinating polyneuropathy in children
by: A. L. Kurenkov, et al.
Published: (2015-02-01) -
Guillain-Barré syndrome as an early complication of a new coronavirus infection SARS-CoV-2 (clinical case)
by: K.Yu. Lytvyn, et al.
Published: (2022-09-01) -
The specific features of Guillain–Barré syndrome in Russia: Analysis of 186 cases
by: N. A. Suponeva, et al.
Published: (2015-02-01)